What class of antidepressants should be avoided in patients with a history of suicide due to their high lethality in overdose situations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tricyclic Antidepressants Should Be Avoided in Suicidal Patients

Tricyclic antidepressants (TCAs) should not be prescribed to patients with a history of suicide due to their highly lethal potential in overdose. 1

Why TCAs Are Dangerous

TCAs have a fatal toxicity index 5 to 8 times higher than newer antidepressants and are the most common cause of death from prescription drug overdose. 2, 3 The American Academy of Child and Adolescent Psychiatry explicitly states that "tricyclics should not be prescribed, because of their greater lethal potential" in suicidal patients. 1

Specific High-Risk TCAs

Within the TCA class, certain agents are particularly lethal:

  • Amoxapine has the highest hazard index (292 per 1000 ingestions), making it the most dangerous antidepressant in overdose 4
  • Maprotiline (hazard index 211) and desipramine (hazard index 187) are also extremely toxic 4
  • Dosulepin and doxepin are 2.6-2.7 times more toxic than amitriptyline, which itself is highly lethal 5

Mechanism of Lethality

TCAs cause death through:

  • Lethal cardiac arrhythmias including QRS prolongation beyond 100 milliseconds 1, 3
  • Rapid clinical deterioration where patients may appear stable initially but "quickly deteriorate and die before your eyes" 6
  • Extreme toxicity in children even at very small doses 6

Safer Alternatives: SSRIs

SSRIs are the preferred antidepressant class for patients with suicide risk because they have dramatically lower lethal potential in overdose. 1, 7

SSRI Safety Profile

  • SSRIs have a hazard index of 0.5 (95% CI 0.4-0.7) compared to TCAs at 13.8 (95% CI 13.0-14.7) 5
  • All SSRIs had low hazard indices in comparative toxicity studies 4
  • The American Academy of Child and Adolescent Psychiatry notes that "in contrast to the highly lethal potential of tricyclic antidepressants when taken in overdoses, SSRIs have low lethal potential" 1

Important SSRI Caveat

Within the SSRI class, citalopram has higher case fatality (1.1) than other SSRIs (0.3), though still far safer than TCAs. 5 Consider fluoxetine, sertraline, or paroxetine as first-line options for maximum safety in overdose.

Other Antidepressants to Avoid

Beyond TCAs, several other agents carry elevated overdose risk:

  • MAO inhibitors fall in the more severe half of antidepressants by hazard index 4
  • Venlafaxine (SNRI) has a case fatality rate ratio of 2.5, intermediate between TCAs and SSRIs 5
  • Bupropion is in the more severe half of antidepressants for overdose toxicity 4

Critical Monitoring Requirements

When SSRIs are prescribed to suicidal patients:

  • Monitor for akathisia, which has been associated with SSRI-induced suicidal ideation, particularly with fluoxetine 1, 7
  • Systematically inquire about suicidal ideation before and after treatment initiation, especially during the first few weeks 1, 7
  • Ensure third-party medication monitoring by family members who can regulate dosage and report mood changes 1, 7
  • Watch for behavioral activation/agitation in the first month, which may require dose reduction 1

Additional Medications to Avoid

Benzodiazepines and phenobarbital should also be avoided in suicidal patients as they may reduce self-control and have disinhibiting effects that can precipitate suicide attempts. 1, 7 Phenobarbital additionally has high lethal potential in overdose. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The toxicity of drugs used for suicide.

Acta psychiatrica Scandinavica. Supplementum, 1993

Research

Managing tricyclic antidepressant overdose.

American family physician, 1992

Research

Suicidal antidepressant overdoses: a comparative analysis by antidepressant type.

Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2008

Research

Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose.

The British journal of psychiatry : the journal of mental science, 2010

Research

Managing antidepression overdoses.

Emergency medical services, 2004

Guideline

Management of Acute Suicidal Ideation in Patients Newly Started on Fluoxetine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.